Zimmer Biomet Reveals FDA Premarket Approval Application Supplement Approval For Oxford Cementless Partial Knee

The approval is based on safety and effectiveness data from an Investigational Device Exemption (IDE) study and non-clinical testing for cementless partial knee replacement.

As part of the U.S. nationwide launch in Q1 2025, Zimmer Biomet will provide FDA-required training, focusing on the cementless surgical technique and proper patient selection.